Results 231 to 240 of about 840,586 (306)

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

Assessing the Effectiveness of the Human Immunodeficiency Virus Point-of-Care Proficiency Testing Scheme: Analysis of the Data From 2021 to 2022 in South Africa. [PDF]

Health Sci Rep
Blasich NP, Adelekan AM.
europepmc   +1 more source

Quality assurance systems – the difficulties in providing a global unified system for Surveyors [PDF]

, 2012
Goodhead, Tim
core  

Clinical Outcomes of SEEG‐Guided Radiofrequency Thermocoagulation in Children With Focal Drug‐Resistant Epilepsy: A Multicenter Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stereoelectroencephalography‐guided radiofrequency thermocoagulation (SEEG‐RFTC) has emerged as a safe and effective minimally invasive treatment for children with drug‐resistant focal epilepsy. Although evidence from real‐world studies remains limited, numerous pediatric cases have demonstrated promising outcomes. This retrospective
Weitao Chen, Stéphane Jean, Weihong Liu, Yihai Dai, Xinrong Fang, Xiaoqiang Wei, Shan Chen, Shiwei Song   +7 more
wiley   +1 more source

Assessing academic capacity and quality assurance in pharmacy education: a focus on the Eastern Mediterranean region. [PDF]

J Pharm Policy Pract
Abedini Z, Awaisu A, Bates I, Mukhalalati B.   +3 more
europepmc   +1 more source

Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness? [PDF]

Europace
Osoro L, Arbelo E, Kozhuharov N, Landen R, Martinek M, Leclerq C, Fauchier L, De Haro JC, Boveda S, Sommer P, Rienstra M, Symanski P, Farkowski M, Egorova A, Moscoso Costa F, Tint D, Simovic S, Dzhinsov K, Leyva F, Boriani G, Figueras J, Ihara Z, Merino JL, Burri H, Pürerfellner H, Casado-Arroyo R.   +25 more
europepmc   +1 more source

Health facilities readiness and associated factors to provide growth monitoring services in low-income and middle-income countries: evidence from national service provision assessment surveys of six countries. [PDF]

BMJ Open
Assefa DT, Belete NK, Gebretsadik MK.
europepmc   +1 more source

Analysis of Anatomical pathology laboratory capabilities in eastern Democratic Republic of Congo. [PDF]

PLOS Glob Public Health
Baharanyi TC, Basengere RA, Tunangoya JY, Hallin M, Budwaga BM, Mukengere EB, Balaluka GB, Mukengere DM, Kozlakidis Z, Lebwaze B, Vandenberg O.   +10 more
europepmc   +1 more source

A nursing-led pathway to safe task sharing in Japan: Interprofessional simulation and a common competency credential. [PDF]

Jpn J Nurs Sci
Kubota K, Nishimura A, Funaki J.
europepmc   +1 more source